RCUS Dividend History & Analysis | N/A Yield
RCUS has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 396,124 M | 3.49% | 7.12% |
| AMGN | 177,758 M | 3.21% | 5.68% |
| GILD | 150,262 M | 2.79% | 5.71% |
| HLN | 44,130 M | 1.76% | 2.46% |
| BIM | 15,041 M | 0.74% | 0.80% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,436 M | 134% | 95.6% |
| HLN | 44,130 M | 30.1% | 100% |
| AMGN | 177,758 M | 7.84% | 100% |
| BIM | 15,041 M | 9.76% | 96.0% |
| ABBV | 396,124 M | 5.98% | 100% |
RCUS Dividend History: as of January 2026
No dividends paid yet.RCUS Dividend FAQ
Arcus Biosciences (NYSE:RCUS) is a clinical-stage biopharma focused on oncology immunotherapies in the United States. Its lead assets include Casdatifan (a HIF-2α inhibitor for renal cell carcinoma) and Domvanalimab (an anti-TIGIT antibody currently in Phase 2/3 trials for lung and gastrointestinal cancers). The pipeline also contains Quemliclustat (CD73 inhibitor in Phase 3 for lung cancer and Phase 1/1b for pancreatic cancer), Etrumadenant (dual A2a/A2b adenosine-receptor antagonist in Phase 2 for colorectal cancer), Zimberelimab (anti-PD-1), AB598 (CD39 antibody in Phase 1/1b for GI cancers) and AB801 (AXL inhibitor in Phase 1b for lung cancer). Arcus collaborates with AstraZeneca on the Phase 3 PACIFIC-8 trial (Domvanalimab + Durvalumab in Stage 3 NSCLC) and on a Phase 1/1b study of Casdatifan + Volrustomig in treatment-naïve clear-cell RCC, and partners with BVF Partners for inflammatory-disease programs.
What is the Dividend Yield of RCUS?
As of January 2026, RCUS`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 24.56.Does RCUS pay a dividend?
As of January 2026 RCUS does not pay a dividend.How often does RCUS pay dividends?
Over the last 12 months, RCUS has issued dividend payments.RCUS dividend forecast
Based on historical data, the forecasted dividends per share for RCUS for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will RCUS pay dividends in 2026?
The next Ex-Dividend date for Arcus Biosciences (RCUS) is currently unknown.What is the next Ex-Dividend Date for RCUS?
The next Ex-Dividend date for Arcus Biosciences (RCUS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of RCUS?
RCUS's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of RCUS?
RCUS's 5-Year Yield on Cost is -%. If you bought RCUS's shares at 36.73 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of RCUS?
RCUS Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does RCUS have a good Dividend Yield?
RCUS`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of RCUS?
The Dividend Payout Ratio of RCUS is unknown.What is the Dividend Rating of RCUS?
RCUS`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-01-15 02:37